Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals

Hayder M. Al‐kuraishy(Mustansiriyah University), Jesús Simal‐Gándara(Universidade de Vigo), ‏Hebatallah M. Saad(Egypt Nanotechnology Center), Ali I. Al‐Gareeb(Mustansiriyah University), Hani Faidah(Umm al-Qura University), Gaber El‐Saber Batiha(Damanhour University)
Inflammopharmacology
August 31, 2022
Cited by 79


Related Papers